Predictive Oncology Strengthens Offerings with GMP Lab and Addition of Leading Expert in Formulation Development
September 19, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced several key developments to further strengthen the company’s offerings for pharmaceutical and...
Predictive Oncology Announces CEO Retirement
September 16, 2022 17:05 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that J. Melville (“Mel”) Engle will retire as Chief Executive Officer and as Chairman and a member...
Predictive Oncology Reports Second Quarter 2022 Financial Results
August 11, 2022 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the financial results for its second quarter ended June 30, 2022, which shows a strong balance...
Predictive Oncology Strengthens Business with Appointment of a Chief Scientific Officer and Consolidation and Expansion of its Research and Development Arm
July 26, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., July 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced a strategic move to further strengthen its business and product offerings by appointing Julia...
Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings
May 18, 2022 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., May 18, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
Predictive Oncology Announces $7.2 Million Registered Direct Offerings
May 16, 2022 08:55 ET
|
Predictive Oncology Inc.
EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
Predictive Oncology Reports First Quarter Financial Results
May 12, 2022 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- The financial results from the first quarter we believe depicts a solid potential for growth in the upcoming period, in accordance with the report by...
Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology
April 26, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that Theresa Ferguson has been named Senior Director of Marketing. As Predictive Oncology’s senior...
Predictive Oncology Reports Year End 2021 Financial Results and Provides Business Update
March 31, 2022 17:25 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 31, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
Predictive Oncology validates Discovery 21 proof-of-concept campaign
March 24, 2022 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, March 24, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) achieved a key milestone toward monetizing its unique approach to leverage artificial intelligence (AI) in oncology...